Considerations for viral co-infection studies in human populations
When respiratory viruses co-circulate in a population, individuals may be infected with multiple pathogens and experience possible virus-virus interactions, where concurrent or recent prior infection with one virus affects the infection process of another virus. While experimental studies have provi...
Gespeichert in:
| Veröffentlicht in: | mBio Jg. 15; H. 7; S. e0065824 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
American Society for Microbiology
17.07.2024
|
| Schlagworte: | |
| ISSN: | 2150-7511, 2161-2129, 2150-7511 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | When respiratory viruses co-circulate in a population, individuals may be infected with multiple pathogens and experience possible virus-virus interactions, where concurrent or recent prior infection with one virus affects the infection process of another virus. While experimental studies have provided convincing evidence for within-host mechanisms of virus-virus interactions, evaluating evidence for viral interference or potentiation using population-level data has proven more difficult. Recent studies have quantified the prevalence of co-detections using populations drawn from clinical settings. Here, we focus on selection bias issues associated with this study design. We provide a quantitative account of the conditions under which selection bias arises in these studies, review previous attempts to address this bias, and propose unbiased study designs with sample size estimates needed to ascertain viral interference. We show that selection bias is expected in cross-sectional co-detection prevalence studies conducted in clinical settings, except under a strict set of assumptions regarding the relative probabilities of being included in a study limited to individuals with clinical disease under different viral states. Population-wide studies that collect samples from participants irrespective of their clinical status would meanwhile require large sample sizes to be sufficiently powered to detect viral interference, suggesting that a study's timing, inclusion criteria, and the expected magnitude of interference are instrumental in determining feasibility. |
|---|---|
| AbstractList | When respiratory viruses co-circulate in a population, individuals may be infected with multiple pathogens and experience possible virus–virus interactions, where concurrent or recent prior infection with one virus affects the infection process of another virus. While experimental studies have provided convincing evidence for within-host mechanisms of virus–virus interactions, evaluating evidence for viral interference or potentiation using population-level data has proven more difficult. Recent studies have quantified the prevalence of co-detections using populations drawn from clinical settings. Here, we focus on selection bias issues associated with this study design. We provide a quantitative account of the conditions under which selection bias arises in these studies, review previous attempts to address this bias, and propose unbiased study designs with sample size estimates needed to ascertain viral interference. We show that selection bias is expected in cross-sectional co-detection prevalence studies conducted in clinical settings, except under a strict set of assumptions regarding the relative probabilities of being included in a study limited to individuals with clinical disease under different viral states. Population-wide studies that collect samples from participants irrespective of their clinical status would meanwhile require large sample sizes to be sufficiently powered to detect viral interference, suggesting that a study’s timing, inclusion criteria, and the expected magnitude of interference are instrumental in determining feasibility. ABSTRACT When respiratory viruses co-circulate in a population, individuals may be infected with multiple pathogens and experience possible virus–virus interactions, where concurrent or recent prior infection with one virus affects the infection process of another virus. While experimental studies have provided convincing evidence for within-host mechanisms of virus–virus interactions, evaluating evidence for viral interference or potentiation using population-level data has proven more difficult. Recent studies have quantified the prevalence of co-detections using populations drawn from clinical settings. Here, we focus on selection bias issues associated with this study design. We provide a quantitative account of the conditions under which selection bias arises in these studies, review previous attempts to address this bias, and propose unbiased study designs with sample size estimates needed to ascertain viral interference. We show that selection bias is expected in cross-sectional co-detection prevalence studies conducted in clinical settings, except under a strict set of assumptions regarding the relative probabilities of being included in a study limited to individuals with clinical disease under different viral states. Population-wide studies that collect samples from participants irrespective of their clinical status would meanwhile require large sample sizes to be sufficiently powered to detect viral interference, suggesting that a study’s timing, inclusion criteria, and the expected magnitude of interference are instrumental in determining feasibility. When respiratory viruses co-circulate in a population, individuals may be infected with multiple pathogens and experience possible virus-virus interactions, where concurrent or recent prior infection with one virus affects the infection process of another virus. While experimental studies have provided convincing evidence for within-host mechanisms of virus-virus interactions, evaluating evidence for viral interference or potentiation using population-level data has proven more difficult. Recent studies have quantified the prevalence of co-detections using populations drawn from clinical settings. Here, we focus on selection bias issues associated with this study design. We provide a quantitative account of the conditions under which selection bias arises in these studies, review previous attempts to address this bias, and propose unbiased study designs with sample size estimates needed to ascertain viral interference. We show that selection bias is expected in cross-sectional co-detection prevalence studies conducted in clinical settings, except under a strict set of assumptions regarding the relative probabilities of being included in a study limited to individuals with clinical disease under different viral states. Population-wide studies that collect samples from participants irrespective of their clinical status would meanwhile require large sample sizes to be sufficiently powered to detect viral interference, suggesting that a study's timing, inclusion criteria, and the expected magnitude of interference are instrumental in determining feasibility.When respiratory viruses co-circulate in a population, individuals may be infected with multiple pathogens and experience possible virus-virus interactions, where concurrent or recent prior infection with one virus affects the infection process of another virus. While experimental studies have provided convincing evidence for within-host mechanisms of virus-virus interactions, evaluating evidence for viral interference or potentiation using population-level data has proven more difficult. Recent studies have quantified the prevalence of co-detections using populations drawn from clinical settings. Here, we focus on selection bias issues associated with this study design. We provide a quantitative account of the conditions under which selection bias arises in these studies, review previous attempts to address this bias, and propose unbiased study designs with sample size estimates needed to ascertain viral interference. We show that selection bias is expected in cross-sectional co-detection prevalence studies conducted in clinical settings, except under a strict set of assumptions regarding the relative probabilities of being included in a study limited to individuals with clinical disease under different viral states. Population-wide studies that collect samples from participants irrespective of their clinical status would meanwhile require large sample sizes to be sufficiently powered to detect viral interference, suggesting that a study's timing, inclusion criteria, and the expected magnitude of interference are instrumental in determining feasibility. |
| Author | Watkins, Timothy A. Lipsitch, Marc Chin, Taylor Foxman, Ellen F. |
| Author_xml | – sequence: 1 givenname: Taylor orcidid: 0000-0001-6852-1169 surname: Chin fullname: Chin, Taylor organization: Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA – sequence: 2 givenname: Ellen F. orcidid: 0000-0001-9767-9942 surname: Foxman fullname: Foxman, Ellen F. organization: Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut, USA, Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA – sequence: 3 givenname: Timothy A. orcidid: 0000-0002-1607-1335 surname: Watkins fullname: Watkins, Timothy A. organization: Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut, USA, Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA – sequence: 4 givenname: Marc orcidid: 0000-0003-1504-9213 surname: Lipsitch fullname: Lipsitch, Marc organization: Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38847531$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kU1v1DAQhi1URMvSI1cUiUuFlOKPOLZPCFYFKlXiAmdr4o_Wq8Re7KQS_x7vbiltpfri0fiZ1zPzvkZHMUWH0FuCzwmh8uM0hHSOcc9lS7sX6IQSjlvBCTl6EB-j01I2uB7GiGT4FTpmUnaCM3KCvqxTLMG6DHOoUeNTbm5DhrExqQ3RO7PLN2VebHClCbG5WSaIzTZtl_FQ8wa99DAWd3p3r9Cvrxc_19_bqx_fLtefr1rgRMytZ8Q5AZbwQWGFHaNECM-s9f3QD17B0FulPFFE8g5AKkmMsZhgQxT1INgKXR50bYKN3uYwQf6jEwS9T6R8rSHPwYxOY-AgMXPSDbRjfadASW7BdqY3HTY7rU8Hre0yTM4aF-c68yPRxy8x3OjrdKvr2jnrKasKZ3cKOf1eXJn1FIpx4wjRpaVoVl1RtQchK_r-CbpJS451V5rRngiKlcCV-nCgoEz0P0Hw7k-pd1brvdW6jrRC7x72f9_4P2Mr0B4Ak1Mp2fl75DlB9oQ3Yd77W8cP4zNVfwF1M8Zk |
| CitedBy_id | crossref_primary_10_1093_cid_ciaf414 crossref_primary_10_1016_j_jviromet_2025_115189 crossref_primary_10_1016_j_ijid_2025_107878 crossref_primary_10_1016_j_jinf_2025_106474 crossref_primary_10_3390_antibiotics13070603 crossref_primary_10_1002_jmv_70399 crossref_primary_10_1038_s41579_025_01225_3 crossref_primary_10_21802_e_GMJ2025_A15 crossref_primary_10_1038_s41467_025_62358_w crossref_primary_10_1093_jac_dkaf043 |
| Cites_doi | 10.1093/infdis/jiac494 10.1371/journal.pbio.3000551 10.3390/v13010139 10.1073/pnas.1911083116 10.1093/infdis/jis494 10.1111/j.1469-0691.2010.03167.x 10.1007/s00430-015-0441-y 10.1126/scitranslmed.3005982 10.1017/S0950268819001055 10.1101/2022.02.04.22270474 10.1016/j.jcv.2022.105249 10.1016/s2666-5247(20)30114-2 10.1016/j.xcrm.2021.100465 10.1371/journal.pcbi.1002135 10.1016/j.jcv.2009.03.008 10.1098/rsif.2015.0627 10.1080/22221751.2021.2021806 10.1128/mSphere.00479-21 10.1016/S2666-5247(20)30218-4 10.1093/cid/civ486 10.1097/EDE.0000000000000870 10.1093/infdis/jiy184 10.1084/jem.20210583 10.1111/irv.12629 10.1098/rspb.1998.0537 10.1371/journal.pone.0199388 10.1093/infdis/jis476 10.2807/ese.14.40.19354-en 10.3201/eid2802.211727 10.1093/infdis/jix031 10.1093/infdis/jiv260 10.1016/S2666-5247(20)30219-6 10.1080/21645515.2017.1287641 10.1128/jvi.00765-22 10.1038/s41422-021-00473-1 10.1097/01.ede.0000135174.63482.43 10.1093/ije/25.6.1107-a |
| ContentType | Journal Article |
| Copyright | Copyright © 2024 Chin et al. 2024. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2024 Chin et al. 2024 Chin et al. |
| Copyright_xml | – notice: Copyright © 2024 Chin et al. – notice: 2024. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2024 Chin et al. 2024 Chin et al. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 8C1 8FE 8FH ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU COVID DWQXO FYUFA GHDGH GNUQQ HCIFZ LK8 M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1128/mbio.00658-24 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Public Health Database (ProQuest) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Database Suite (ProQuest) Natural Science Collection ProQuest One Coronavirus Research Database ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Biological Science Collection Biological Science Database (ProQuest) ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Public Health ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Coronavirus Research Database Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2150-7511 |
| Editor | Prasad, Vinayaka R. Dushoff, Jonathan |
| Editor_xml | – sequence: 1 givenname: Vinayaka R. surname: Prasad fullname: Prasad, Vinayaka R. – sequence: 2 givenname: Jonathan surname: Dushoff fullname: Dushoff, Jonathan |
| ExternalDocumentID | oai_doaj_org_article_0a5a803e8eb243649a985dad4c6c40c7 PMC11253623 00658-24 38847531 10_1128_mbio_00658_24 |
| Genre | Journal Article Review |
| GrantInformation_xml | – fundername: Rita Allen Foundation (RAF) – fundername: NIAID NIH HHS grantid: T32 AI007535 – fundername: HHS | National Institutes of Health (NIH) grantid: 2T32AI007535 – fundername: HHS | NIH | National Cancer Institute (NCI) grantid: 1U01CA261277 – fundername: NCI NIH HHS grantid: U01 CA261277 – fundername: HHS | National Institutes of Health (NIH) grantid: T32AI007019 – fundername: GMU | Mercatus Center, George Mason University (Mercatus Center) grantid: FastGrants for COVID-19 – fundername: NIAID NIH HHS grantid: T32 AI007019 – fundername: ; – fundername: ; grantid: 1U01CA261277 – fundername: ; grantid: FastGrants for COVID-19 – fundername: ; grantid: T32AI007019 – fundername: ; grantid: 2T32AI007535 |
| GroupedDBID | --- 0R~ 53G 5VS 8C1 AAFWJ AAGFI AAUOK AAYXX ABUWG ADBBV AENEX AFFHD AFKRA AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BBNVY BCNDV BENPR BHPHI BTFSW CCPQU CITATION DIK E3Z EBS FRP FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HYE HZ~ KQ8 M48 M7P O5R O5S O9- OK1 P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB RHI RNS RPM RSF UKHRP CGR CUY CVF ECM EIF NPM M~E RHF 8FE 8FH AZQEC COVID DWQXO GNUQQ LK8 PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-a517t-f31ee7ad15b9090e32177f3ddf6b6bf9ab6d99f191854aa8981ccd010c192fa73 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 11 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001240350300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2150-7511 2161-2129 |
| IngestDate | Fri Oct 03 12:50:41 EDT 2025 Tue Nov 04 02:05:35 EST 2025 Thu Oct 02 03:59:58 EDT 2025 Tue Oct 21 14:13:25 EDT 2025 Wed Jul 17 18:30:29 EDT 2024 Mon Jul 21 06:06:46 EDT 2025 Sat Nov 29 02:07:51 EST 2025 Tue Nov 18 21:44:15 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | selection bias co-detections epidemiology virus–virus interactions |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. https://creativecommons.org/licenses/by/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a517t-f31ee7ad15b9090e32177f3ddf6b6bf9ab6d99f191854aa8981ccd010c192fa73 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 The authors declare no conflict of interest. |
| ORCID | 0000-0001-9767-9942 0000-0003-1504-9213 0000-0001-6852-1169 0000-0002-1607-1335 |
| OpenAccessLink | https://doaj.org/article/0a5a803e8eb243649a985dad4c6c40c7 |
| PMID | 38847531 |
| PQID | 3261720970 |
| PQPubID | 7421146 |
| PageCount | 12 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_0a5a803e8eb243649a985dad4c6c40c7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11253623 proquest_miscellaneous_3065980378 proquest_journals_3261720970 asm2_journals_10_1128_mbio_00658_24 pubmed_primary_38847531 crossref_primary_10_1128_mbio_00658_24 crossref_citationtrail_10_1128_mbio_00658_24 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-07-17 |
| PublicationDateYYYYMMDD | 2024-07-17 |
| PublicationDate_xml | – month: 07 year: 2024 text: 2024-07-17 day: 17 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC – name: Washington |
| PublicationTitle | mBio |
| PublicationTitleAbbrev | mBio |
| PublicationTitleAlternate | mBio |
| PublicationYear | 2024 |
| Publisher | American Society for Microbiology |
| Publisher_xml | – name: American Society for Microbiology |
| References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 Woodward M (e_1_3_2_34_2) 2014 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_14_2 e_1_3_2_35_2 Takashima, MD, Grimwood, K, Sly, PD, Lambert, SB, Ware, RS (B32) 2022; 155 B25 Essaidi-Laziosi, M, Alvarez, C, Puhach, O, Sattonnet-Roche, P, Torriani, G, Tapparel, C, Kaiser, L, Eckerle, I (B6) 2022; 11 Ndifon, W (B23) 2015; 12 Shrestha, S, Foxman, B, Weinberger, DM, Steiner, C, Viboud, C, Rohani, P (B37) 2013; 5 Dee, K, Schultz, V, Haney, J, Bissett, LA, Magill, C, Murcia, PR (B9) 2023; 227 Boikos, C, Papenburg, J, Martineau, C, Joseph, L, Scheifele, D, Chilvers, M, Lands, LC, De Serres, G, Quach, C (B28) 2017; 13 Chan, KF, Carolan, LA, Korenkov, D, Druce, J, McCaw, J, Reading, PC, Barr, IG, Laurie, KL (B19) 2018; 218 Oishi, K, Horiuchi, S, Minkoff, JM (B7) 2022; 96 Nickbakhsh, S, Mair, C, Matthews, L, Reeve, R, Johnson, PCD, Thorburn, F, von Wissmann, B, Reynolds, A, McMenamin, J, Gunson, RN, Murcia, PR (B36) 2019; 116 Van Leuven, JT, Gonzalez, AJ, Ijezie, EC, Wixom, AQ, Clary, JL, Naranjo, MN, Ridenhour, BJ, Miller, CR, Miura, TA (B8) 2021; 6 Laurie, KL, Guarnaccia, TA, Carolan, LA, Yan, AWC, Aban, M, Petrie, S, Cao, P, Heffernan, JM, McVernon, J, Mosse, J, Kelso, A, McCaw, JM, Barr, IG (B26) 2015; 212 Shrestha, S, King, AA, Rohani, P (B38) 2011; 7 Piret, J, Boivin, G (B1) 2022; 28 Hamelin, FM, Allen, LJS, Bokil, VA, Gross, LJ, Hilker, FM, Jeger, MJ, Manore, CA, Power, AG, Rúa, MA, Cunniffe, NJ (B11) 2019; 17 Goto, H, Ihira, H, Morishita, K, Tsuchiya, M, Ohta, K, Yumine, N, Tsurudome, M, Nishio, M (B20) 2016; 205 Burstein, R, Althouse, BM, Adler, A, Akullian, A, Brandstetter, E, Cho, S, Emanuels, A, Fay, K, Gamboa, L, Han, P (B17) 2022 Wu, A, Mihaylova, VT, Landry, ML, Foxman, EF (B18) 2021; 2 Casalegno, JS, Ottmann, M, Duchamp, MB, Escuret, V, Billaud, G, Frobert, E, Morfin, F, Lina, B (B34) 2010; 16 Wu, A, Mihaylova, VT, Landry, ML, Foxman, EF (B3) 2020; 1 Bai, L, Zhao, Y, Dong, J, Liang, S, Guo, M, Liu, X, Wang, X, Huang, Z, Sun, X, Zhang, Z (B21) 2021; 31 Hernán, MA, Hernández-Díaz, S, Robins, JM (B2) 2004; 15 Achten, NB, Wu, P, Bont, L, Blanken, MO, Gebretsadik, T, Chappell, JD, Wang, L, Yu, C, Larkin, EK, Carroll, KN, Anderson, LJ, Moore, ML, Sloan, CD, Hartert, TV (B15) 2017; 215 Nordén, R, Lindh, M, Nilsson, S, Westin, J (B16) 2021; 2 Durham, DP, Poolman, EM, Ibuka, Y, Townsend, JP, Galvani, AP (B39) 2012; 206 Woodward, M (B33) 2014 Cheemarla, NR, Watkins, TA, Mihaylova, VT, Wang, B, Zhao, D, Wang, G, Landry, ML, Foxman, EF (B4) 2021; 218 Costa-Martins, AG, Mane, K, Lindsey, BB, Ogava, RLT, Castro, Í, Jagne, YJ, Sallah, HJ, Armitage, EP, Jarju, S, Ahadzie, B, Ellis-Watson, R, Tregoning, JS, Bingle, CD, Bogaert, D, Clarke, E, Ordovas-Montanes, J, Jeffries, D, Kampmann, B, Nakaya, HI, de Silva, TI (B27) 2021; 2 Rohani, P, Earn, DJ, Finkenstädt, B, Grenfell, BT (B22) 1998; 265 Galanti, M, Birger, R, Ud-Dean, M, Filip, I, Morita, H, Comito, D, Anthony, S, Freyer, GA, Ibrahim, S, Lane, B, Ligon, C, Rabadan, R, Shittu, A, Tagne, E, Shaman, J (B29) 2019; 13 Byington, CL, Ampofo, K, Stockmann, C, Adler, FR, Herbener, A, Miller, T, Sheng, X, Blaschke, AJ, Crisp, R, Pavia, AT (B30) 2015; 61 Man, I, Wallinga, J, Bogaards, JA (B10) 2018; 29 Mackay, IM, Lambert, SB, Faux, CE, Arden, KE, Nissen, MD, Sloots, TP, Nolan, TM (B13) 2013; 207 Adler, FR, Stockmann, C, Ampofo, K, Pavia, AT, Byington, CL (B31) 2018; 13 Greenland, S (B24) 1996; 25 Geiser, J, Boivin, G, Huang, S, Constant, S, Kaiser, L, Tapparel, C, Essaidi-Laziosi, M (B5) 2021; 13 Price, OH, Sullivan, SG, Sutterby, C, Druce, J, Carville, KS (B12) 2019; 147 Greer, RM, McErlean, P, Arden, KE, Faux, CE, Nitsche, A, Lambert, SB, Nissen, MD, Sloots, TP, Mackay, IM (B14) 2009; 45 Linde, A, Rotzén-Ostlund, M, Zweygberg-Wirgart, B, Rubinova, S, Brytting, M (B35) 2009; 14 |
| References_xml | – ident: e_1_3_2_10_2 doi: 10.1093/infdis/jiac494 – ident: e_1_3_2_12_2 doi: 10.1371/journal.pbio.3000551 – ident: e_1_3_2_6_2 doi: 10.3390/v13010139 – ident: e_1_3_2_37_2 doi: 10.1073/pnas.1911083116 – ident: e_1_3_2_40_2 doi: 10.1093/infdis/jis494 – ident: e_1_3_2_35_2 doi: 10.1111/j.1469-0691.2010.03167.x – ident: e_1_3_2_21_2 doi: 10.1007/s00430-015-0441-y – ident: e_1_3_2_38_2 doi: 10.1126/scitranslmed.3005982 – ident: e_1_3_2_13_2 doi: 10.1017/S0950268819001055 – ident: e_1_3_2_18_2 doi: 10.1101/2022.02.04.22270474 – ident: e_1_3_2_33_2 doi: 10.1016/j.jcv.2022.105249 – ident: e_1_3_2_4_2 doi: 10.1016/s2666-5247(20)30114-2 – ident: e_1_3_2_28_2 doi: 10.1016/j.xcrm.2021.100465 – ident: e_1_3_2_39_2 doi: 10.1371/journal.pcbi.1002135 – ident: e_1_3_2_15_2 doi: 10.1016/j.jcv.2009.03.008 – ident: e_1_3_2_24_2 doi: 10.1098/rsif.2015.0627 – ident: e_1_3_2_26_2 – ident: e_1_3_2_7_2 doi: 10.1080/22221751.2021.2021806 – ident: e_1_3_2_9_2 doi: 10.1128/mSphere.00479-21 – ident: e_1_3_2_19_2 doi: 10.1016/S2666-5247(20)30218-4 – ident: e_1_3_2_31_2 doi: 10.1093/cid/civ486 – ident: e_1_3_2_11_2 doi: 10.1097/EDE.0000000000000870 – ident: e_1_3_2_20_2 doi: 10.1093/infdis/jiy184 – ident: e_1_3_2_5_2 doi: 10.1084/jem.20210583 – ident: e_1_3_2_30_2 doi: 10.1111/irv.12629 – ident: e_1_3_2_23_2 doi: 10.1098/rspb.1998.0537 – ident: e_1_3_2_32_2 doi: 10.1371/journal.pone.0199388 – ident: e_1_3_2_14_2 doi: 10.1093/infdis/jis476 – ident: e_1_3_2_36_2 doi: 10.2807/ese.14.40.19354-en – ident: e_1_3_2_2_2 doi: 10.3201/eid2802.211727 – ident: e_1_3_2_16_2 doi: 10.1093/infdis/jix031 – ident: e_1_3_2_27_2 doi: 10.1093/infdis/jiv260 – ident: e_1_3_2_17_2 doi: 10.1016/S2666-5247(20)30219-6 – ident: e_1_3_2_29_2 doi: 10.1080/21645515.2017.1287641 – ident: e_1_3_2_8_2 doi: 10.1128/jvi.00765-22 – ident: e_1_3_2_22_2 doi: 10.1038/s41422-021-00473-1 – ident: e_1_3_2_3_2 doi: 10.1097/01.ede.0000135174.63482.43 – volume-title: Epidemiology: Study design and data analysis year: 2014 ident: e_1_3_2_34_2 – ident: e_1_3_2_25_2 doi: 10.1093/ije/25.6.1107-a – ident: B25 article-title: Human challenge trials for vaccine development: regulatory considerations, annex 10, TRS no 1004 . 2017 . Available from : https://www.who.int/publications/m/item/human-challenge-trials-for-vaccine-a10-trs-no-1004 . Retrieved 7 Jan 2023 . – volume: 2 year: 2021 ident: B18 article-title: Viral interference cannot be concluded from datasets containing only symptomatic patients – authors’ reply publication-title: Lancet Microbe doi: 10.1016/S2666-5247(20)30218-4 – volume: 147 year: 2019 ident: B12 article-title: Using routine testing data to understand circulation patterns of influenza A, respiratory syncytial virus and other respiratory viruses in Victoria, Australia publication-title: Epidemiol Infect doi: 10.1017/S0950268819001055 – volume: 6 year: 2021 ident: B8 article-title: Rhinovirus reduces the severity of subsequent respiratory viral infections by interferon-dependent and -independent mechanisms publication-title: mSphere doi: 10.1128/mSphere.00479-21 – volume: 17 year: 2019 ident: B11 article-title: Coinfections by noninteracting pathogens are not independent and require new tests of interaction publication-title: PLOS Biol doi: 10.1371/journal.pbio.3000551 – volume: 206 start-page: 1291 year: 2012 end-page: 1298 ident: B39 article-title: Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types publication-title: J Infect Dis doi: 10.1093/infdis/jis494 – volume: 7 year: 2011 ident: B38 article-title: Statistical inference for multi-pathogen systems publication-title: PLOS Comput Biol doi: 10.1371/journal.pcbi.1002135 – volume: 29 start-page: 666 year: 2018 end-page: 674 ident: B10 article-title: Inferring pathogen type interactions using cross-sectional prevalence data: opportunities and pitfalls for predicting type replacement publication-title: Epidemiology doi: 10.1097/EDE.0000000000000870 – volume: 96 year: 2022 ident: B7 article-title: The host response to influenza A virus interferes with SARS-CoV-2 replication during coinfection publication-title: J Virol doi: 10.1128/jvi.00765-22 – volume: 2 year: 2021 ident: B16 article-title: Viral interference cannot be concluded from datasets containing only symptomatic patients publication-title: Lancet Microbe doi: 10.1016/S2666-5247(20)30219-6 – volume: 16 start-page: 326 year: 2010 end-page: 329 ident: B34 article-title: Rhinoviruses delayed the circulation of the pandemic influenza A (H1N1) 2009 virus in France publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2010.03167.x – volume: 205 start-page: 209 year: 2016 end-page: 218 ident: B20 article-title: Enhanced growth of influenza A virus by coinfection with human parainfluenza virus type 2 publication-title: Med Microbiol Immunol doi: 10.1007/s00430-015-0441-y – volume: 28 start-page: 273 year: 2022 end-page: 281 ident: B1 article-title: Viral interference between respiratory viruses publication-title: Emerg Infect Dis doi: 10.3201/eid2802.211727 – volume: 5 start-page: 191ra84 year: 2013 end-page: 191ra84 ident: B37 article-title: Identifying the interaction between influenza and Pneumococcal pneumonia using incidence data publication-title: Sci Transl Med doi: 10.1126/scitranslmed.3005982 – volume: 218 year: 2021 ident: B4 article-title: Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics publication-title: J Exp Med doi: 10.1084/jem.20210583 – volume: 116 start-page: 27142 year: 2019 end-page: 27150 ident: B36 article-title: Virus–virus interactions impact the population dynamics of influenza and the common cold publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1911083116 – volume: 45 start-page: 10 year: 2009 end-page: 15 ident: B14 article-title: Do rhinoviruses reduce the probability of viral co-detection during acute respiratory tract infections publication-title: J Clin Virol doi: 10.1016/j.jcv.2009.03.008 – volume: 11 start-page: 412 year: 2022 end-page: 423 ident: B6 article-title: Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract publication-title: Emerg Microbes Infect doi: 10.1080/22221751.2021.2021806 – year: 2022 ident: B17 article-title: Interactions among 17 respiratory pathogens: a cross-sectional study using clinical and community surveillance data publication-title: medRxiv doi: 10.1101/2022.02.04.22270474 – volume: 13 year: 2021 ident: B5 article-title: RSV and HMPV infections in 3D tissue cultures: mechanisms involved in virus-host and virus-virus interactions publication-title: Viruses doi: 10.3390/v13010139 – volume: 13 start-page: 226 year: 2019 end-page: 232 ident: B29 article-title: Longitudinal active sampling for respiratory viral infections across age groups publication-title: Influenza Other Respir Viruses doi: 10.1111/irv.12629 – volume: 218 start-page: 406 year: 2018 end-page: 417 ident: B19 article-title: Investigating viral interference between influenza A virus and human respiratory syncytial virus in a ferret model of infection publication-title: J Infect Dis doi: 10.1093/infdis/jiy184 – volume: 25 start-page: 1107 year: 1996 end-page: 1116 ident: B24 article-title: Basic methods for sensitivity analysis of biases publication-title: Int J Epidemiol doi: 10.1093/ije/25.6.1107-a – volume: 265 start-page: 2033 year: 1998 end-page: 2041 ident: B22 article-title: Population dynamic interference among childhood diseases publication-title: Proc Biol Sci doi: 10.1098/rspb.1998.0537 – volume: 13 start-page: 1254 year: 2017 end-page: 1260 ident: B28 article-title: Viral interference and the live-attenuated intranasal influenza vaccine: results from a pediatric cohort with cystic fibrosis publication-title: Hum Vaccines Immunother doi: 10.1080/21645515.2017.1287641 – volume: 61 start-page: 1217 year: 2015 end-page: 1224 ident: B30 article-title: Community surveillance of respiratory viruses among families in the Utah better identification of germs-longitudinal viral epidemiology (BIG-LoVE) study publication-title: Clin Infect Dis doi: 10.1093/cid/civ486 – year: 2014 ident: B33 article-title: Epidemiology publication-title: Epidemiology: Study design and data analysis ;Third Edition, 3rd edn ;In ;Chapman and Hall/CRC ;New York – volume: 1 start-page: e254 year: 2020 end-page: e262 ident: B3 article-title: Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study publication-title: Lancet Microbe doi: 10.1016/s2666-5247(20)30114-2 – volume: 31 start-page: 395 year: 2021 end-page: 403 ident: B21 article-title: Coinfection with influenza A virus enhances SARS-CoV-2 infectivity publication-title: Cell Res doi: 10.1038/s41422-021-00473-1 – volume: 215 start-page: 1102 year: 2017 end-page: 1106 ident: B15 article-title: Interference between respiratory syncytial virus and human rhinovirus infection in infancy publication-title: J Infect Dis doi: 10.1093/infdis/jix031 – volume: 207 start-page: 1433 year: 2013 end-page: 1441 ident: B13 article-title: Community-wide, contemporaneous circulation of a broad spectrum of human rhinoviruses in healthy Australian preschool-aged children during a 12-month period publication-title: J Infect Dis doi: 10.1093/infdis/jis476 – volume: 212 start-page: 1701 year: 2015 end-page: 1710 ident: B26 article-title: Interval between infections and viral hierarchy are determinants of viral interference following influenza virus infection in a ferret model publication-title: J Infect Dis doi: 10.1093/infdis/jiv260 – volume: 12 year: 2015 ident: B23 article-title: A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants publication-title: J R Soc Interface doi: 10.1098/rsif.2015.0627 – volume: 15 start-page: 615 year: 2004 end-page: 625 ident: B2 article-title: A structural approach to selection bias publication-title: Epidemiol Camb Mass doi: 10.1097/01.ede.0000135174.63482.43 – volume: 14 year: 2009 ident: B35 article-title: Does viral interference affect spread of influenza? publication-title: Euro Surveill doi: 10.2807/ese.14.40.19354-en – volume: 227 start-page: 1396 year: 2023 end-page: 1406 ident: B9 article-title: Influenza A and respiratory syncytial virus trigger a cellular response that blocks severe acute respiratory syndrome virus 2 infection in the respiratory tract publication-title: J Infect Dis doi: 10.1093/infdis/jiac494 – volume: 2 year: 2021 ident: B27 article-title: Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in children publication-title: Cell Rep Med doi: 10.1016/j.xcrm.2021.100465 – volume: 155 start-page: 105249 year: 2022 ident: B32 article-title: Interference between rhinovirus and other RNA respiratory viruses in the first 2-years of life: a longitudinal community-based birth cohort study publication-title: J Clin Virol doi: 10.1016/j.jcv.2022.105249 – volume: 13 year: 2018 ident: B31 article-title: Transmission of rhinovirus in the Utah BIG-LoVE families: consequences of age and household structure publication-title: PLoS ONE doi: 10.1371/journal.pone.0199388 |
| SSID | ssj0000331830 |
| Score | 2.4444304 |
| SecondaryResourceType | review_article |
| Snippet | When respiratory viruses co-circulate in a population, individuals may be infected with multiple pathogens and experience possible virus-virus interactions,... When respiratory viruses co-circulate in a population, individuals may be infected with multiple pathogens and experience possible virus–virus interactions,... ABSTRACT When respiratory viruses co-circulate in a population, individuals may be infected with multiple pathogens and experience possible virus–virus... |
| SourceID | doaj pubmedcentral proquest asm2 pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0065824 |
| SubjectTerms | Adaptive immunity Bias co-detections Coinfection - epidemiology Coinfection - virology Cross-Sectional Studies Epidemiology Humans Minireview Population Population studies Prevalence Respiratory Tract Infections - epidemiology Respiratory Tract Infections - virology Selection Bias Viral infections Viral Interference Virus Diseases - epidemiology Virus Diseases - virology Viruses Viruses - classification Viruses - genetics Viruses - isolation & purification virus–virus interactions |
| SummonAdditionalLinks | – databaseName: Public Health Database (ProQuest) dbid: 8C1 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BAhIX3oXQgoJAnDD1I36dEK2oOFUcQOotcvyAldpku9ki8e-xnUe7iHLhmowiOzNjfzMezwfwxjEdYxwpECeGoXR1EWnLYswjSRMoNcxyl8km5PGxOjnRX8aEWz-WVU5rYl6oXWdTjnyfpdbhFGuJP6zOUWKNSqerI4XGTbhFaDTHdFP8kMw5FsySxaY0C43ABsVVWk9tNqnaP2uW3fu8BaN0331h-jO6tTvlJv5_Q55_FlBe2ZGO7v_vXB7AvRGLlh8H43kIN3z7CO4M7JS_HsPBROY5JPXKCG_LVBJ8WtoOTUVcbdkPlYjlsi0z4V-5mjnB-ifw7ejT18PPaKRcQIYTuUGBEe-lcYQ3GmvsWYxYZGDOBdGIJmjTCKd1iEGe4pUxSitirYsxnY1IMRjJdmDRdq1_BmWjgyLCCS1JqLjXKkVGwbMgHLaMhwJepz9ejz7T1zkcoapOeqmzXmpaFfBuUkhtx67liTzj9Drxt7P4amjXcZ3gQdLuLJS6bOcH3fp7PTptjQ03CjOvfEMrJipttOLOuMoKW2ErC9ib9Hs5jUvlFvBqfh2dNp3EmNZ3F1EmnWbHL0tVwNPBlOaRMBUBQ1wZC1BbRrY11O037fJHbgwep8kjIGHP_z2uXbhLIzRDuT3oHiw26wv_Am7bn5tlv36ZXeg3ddMiVA priority: 102 providerName: ProQuest |
| Title | Considerations for viral co-infection studies in human populations |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38847531 https://journals.asm.org/doi/10.1128/mbio.00658-24 https://www.proquest.com/docview/3261720970 https://www.proquest.com/docview/3065980378 https://pubmed.ncbi.nlm.nih.gov/PMC11253623 https://doaj.org/article/0a5a803e8eb243649a985dad4c6c40c7 |
| Volume | 15 |
| WOSCitedRecordID | wos001240350300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2150-7511 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000331830 issn: 2150-7511 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Biological Science Database (ProQuest) customDbUrl: eissn: 2150-7511 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000331830 issn: 2150-7511 databaseCode: M7P dateStart: 20100501 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central Database Suite (ProQuest) customDbUrl: eissn: 2150-7511 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000331830 issn: 2150-7511 databaseCode: BENPR dateStart: 20100501 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 2150-7511 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000331830 issn: 2150-7511 databaseCode: PIMPY dateStart: 20100501 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database (ProQuest) customDbUrl: eissn: 2150-7511 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000331830 issn: 2150-7511 databaseCode: 8C1 dateStart: 20100501 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB7BAhIXxJtAWQWBOBHqxPHryFat4MAqQiAtp8jxQ12pzVbNFol_z9h5sIuouHDJwRlF9njsmS8efwPwxlKFGEfwjOWaZuHqYqYMRcwj8sYXhaaG2VhsQiyXcrVS1U6pr5AT1tMD94o7JJppSaiTCAFLykullWRW29JwUxIT75EToXbAVNyDabBVMpJqFvLwvFlv3keHm4Xb7TPdnRd7vihS9v8tzvwzXXLH_5zch3tD4Jh-6Dv8AG649iHc6UtJ_nwEi7HyZv8HLsVYNA35u2ep2WRjxlWbdn3aYLpu01idL72YCnh1j-HbyfHXo4_ZUB8h0ywX28zT3Dmhbc4aRRRxFOGF8NRazxveeKUbbpXyiMgkK7WWSubGWARgBsM6rwV9ArN207pnkDbKy5xbrkTuS-aUDDDGO-q5JYYyn8DroLB6MPCujtihkHVQax3VWhdlAu9GfdZmoBgPlS7OrhN_O4lf9Nwa1wkuwuRMQoESOzagodSDodT_MpQEDsap_T0MGgjpC6IESeDV9BpXWDg20a3bXKFMOHrGLwuZwNPeEqaeUIneHbexBOSejex1df9Nuz6NLN44TIbRA33-Pwb3Au4WGG1lkfHzAGbbyyv3Em6bH9t1dzmHm2Il8SmP8jncWhwvqy_zuF7mIdW1wrbq0-fq-y_Oqxjd |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VBQQX3o9AASOgJ0wTO47tA0K0ULVqWXEoUm_B8QNWapNlswX1T_EbsZ1NyiLKrQeuySiy48_jb-zxfADPDZU-xuEFZpmiOFxdxFJTH_PwrHKEKKqZiWITfDwWBwfy4wr87O_ChLTK3idGR20aHfbI12koHU5SydM30284qEaF09VeQqODxa49-eFDtvb1zjs_vi8I2Xq_v7mNF6oCWLGMz7GjmbVcmYxVMpWppZ6Uc0eNcUVVVE6qqjBSOh_HCJYrJaTItDY-bNGeDDnFqf_uBbiYU0LDLBKb2bCnk9IwQ8K2DvFECvtVQfZlPYlYP6omzau45ONwv36k2iOytBpG0YC_Md0_EzZ_WwG3rv9v_-4GXFtwbfS2mxw3YcXWt-Byp755chs2erHSbtMSefqOQsrzIdIN7pPUatR2mZZoUqMoaIimg-ZZewc-nUsH7sKobmp7H1AlncgKU0ieuZxZKULk5yx1hUk1ZS6BZ2GEy4VPaMsYbhFRBhyUEQclyRN42QOg1Iuq7EEc5PAs87XBfNqVIznLcCOgaTAKVcTjg2b2pVw4pTJVTImUWmErktMil0oKZpTJdaHzVPMEVns8nXbjFEwJPB1ee6cUTppUbZtjbxNO6_2XuUjgXgfdoSVUeELkPX8CYgnUS01dflNPvsbC576bzBMu-uDf7XoCV7b3P-yVezvj3YdwlXgaimMp1FUYzWfH9hFc0t_nk3b2OE5fBJ_PG_O_AIowgDM |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Considerations+for+viral+co-infection+studies+in+human+populations&rft.jtitle=mBio&rft.au=Taylor+Chin&rft.au=Ellen+F.+Foxman&rft.au=Timothy+A.+Watkins&rft.au=Marc+Lipsitch&rft.date=2024-07-17&rft.pub=American+Society+for+Microbiology&rft.eissn=2150-7511&rft.volume=15&rft.issue=7&rft_id=info:doi/10.1128%2Fmbio.00658-24&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_0a5a803e8eb243649a985dad4c6c40c7 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2150-7511&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2150-7511&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2150-7511&client=summon |